Aging Clinical Trial - Personal Variables Affecting the Successful Aging

Status Completed

Clinical Trial Summary

Three hundreds patients aged 60 years and older applicant for any reasons between January 3, 2019 and May 30, 2019, in Health Sciences University Haydarpaşa Numune Training and Research Hospital Family Medicine Polyclinics. A 21-item questionnaire including demographic information was asked to the individuals who gave consent to participate in the study, voluntarily, and who met the participation criteria and the Successful Aging Scale was administered face-to-face with the questionnaire method. Participants were evaluated under two subheadings according to the Successful Aging Scale and the results were compared with their demographic characteristics.

Clinical Trial Description

In our cross-sectional study; the target sample size was calculated as 299, with a population of 1350. The prevalence was 50%, the standard error was 5% in a 95% confidence interval. Between 03.01.2019 and 30.05.2019; 300 elderly volunteers who applied to the Health Sciences University Haydarpaşa Numune Training and Research Hospital Family Medicine Polyclinics for any reason, who were not diagnosed with neuropsychiatric disease, do not had physical or mental problems that would prevent them from understanding and filling the scales and do not have a health problem that require urgent intervention are included. Participants were informed, their consent was taken, and a 21-item sociodemographic form prepared by the researchers was applied. Afterwards, a 7-point Likert-type "Successful Aging Scale" (SAS) consisting of 10 questions was applied to the participants.16 The scale had two sub-components, namely "healthy lifestyle" (HL) and "adaptive coping" (AC). The values of the expressions in the scale were as "strongly agree:7, agree:6, partially agree:5, undecided:4, partially disagree:3, disagree:2, strongly disagree:1". The values for each individual were summed up and the scale was evaluated by subtracting the total score. Finally, the results from the questionnaire and the Successful Aging Scale were compared and analyzed according to subcomponents. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06204224
Study type	Observational
Source	Marmara University Pendik Training and Research Hospital
Contact
Status	Completed
Phase
Start date	January 3, 2019
Completion date	May 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05433233` - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension	N/A
Recruiting	`NCT06032065` - SMART Exercise for PAD	Phase 3
Active, not recruiting	`NCT05293730` - Trial of the Impact of the Electronic Frailty Integrated With Social Needs	N/A
Recruiting	`NCT03932162` - Gene Expression Changes In Young and Geriatric Skin	Early Phase 1
Completed	`NCT04064528` - Effects of Age on Amino Acid Delivery to Tendon	N/A
Active, not recruiting	`NCT03366129` - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed	`NCT06029920` - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment	N/A
Recruiting	`NCT05566938` - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly	N/A
Recruiting	`NCT05543980` - Leg Heat Therapy in Elderly Individuals	Phase 2
Completed	`NCT04894929` - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement	N/A
Not yet recruiting	`NCT06071130` - Emotion, Aging, and Decision Making	N/A
Enrolling by invitation	`NCT04641663` - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)	N/A
Completed	`NCT04088006` - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity	N/A
Completed	`NCT03695081` - Patient Pathway Pharmacist - Optimal Drug-related Care	N/A
Recruiting	`NCT05424263` - Acetate and Age-associated Arterial Dysfunction	Phase 2
Completed	`NCT05601713` - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling	N/A
Completed	`NCT04551339` - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19	N/A
Recruiting	`NCT04997577` - Speech Perception and High Cognitive Demand	N/A
Completed	`NCT05922475` - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training	N/A
Completed	`NCT04015479` - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.